INS and Paralysis: Together, these adaptations foster an unstable systemic metabolism supported by elevated biomarkers for inflammation (C-reactive protein), abnormal lipid profiles, and abnormal glycemic control (glucose, insulin, lactate) in people with paralysis [13,14,27].